TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -21.78%55.7M | 411.83%950.27M | -41.39%71.21M | -70.39%185.66M | -65.07%121.49M | 16.37%626.99M | 4.54%347.81M | -63.07%538.79M | -59.67%332.69M | -18.66%1.46B |
Operating income | -21.78%55.7M | 411.83%950.27M | -41.39%71.21M | -70.39%185.66M | -65.07%121.49M | 16.37%626.99M | 4.54%347.81M | -63.07%538.79M | -59.67%332.69M | -18.66%1.46B |
Cost of sales | 13.81%-41.31M | -484.05%-887.22M | 50.53%-47.93M | 73.67%-151.91M | 68.79%-96.88M | -57.79%-577.03M | -29.85%-310.37M | 62.24%-365.69M | 54.97%-239.02M | 16.35%-968.39M |
Operating expenses | 13.81%-41.31M | -484.05%-887.22M | 50.53%-47.93M | 73.67%-151.91M | 68.79%-96.88M | -57.79%-577.03M | -29.85%-310.37M | 62.24%-365.69M | 54.97%-239.02M | 16.35%-968.39M |
Gross profit | -38.18%14.39M | 86.80%63.05M | -5.39%23.28M | -32.44%33.75M | -34.27%24.61M | -71.14%49.96M | -60.03%37.44M | -64.71%173.1M | -68.14%93.67M | -22.86%490.44M |
Selling expenses | 47.78%-3.24M | 7.35%-15.17M | 26.67%-6.2M | 1.87%-16.37M | 41.15%-8.46M | 39.48%-16.68M | 5.73%-14.37M | 38.28%-27.56M | 29.88%-15.24M | 22.22%-44.66M |
Administrative expenses | 32.70%-44.89M | 24.95%-116.06M | 21.38%-66.69M | 38.99%-154.64M | 27.75%-84.83M | 36.41%-253.49M | 48.41%-117.4M | 25.84%-398.63M | 21.43%-227.59M | 12.19%-537.51M |
Profit from asset sales | ---- | ---- | ---- | --350.03M | --341.93M | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | ---- | 90.58%-1.23M | ---- | 56.80%-13.1M | ---- | 33.45%-30.31M | ---- | ---45.55M | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 85.44%-3.87M | ---- | ---26.56M | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.52M | ---- | ---- |
-Other impairment is provision | ---- | 90.58%-1.23M | ---- | 50.49%-13.1M | ---- | -96.27%-26.45M | ---- | ---13.48M | ---- | ---- |
Special items of operating profit | -60.68%41.23M | 24,332.63%137.4M | 1,781.23%104.86M | -100.77%-567K | 197.06%5.57M | -9.35%73.73M | -115.95%-5.74M | 301.13%81.34M | 362.11%36M | 15.26%20.28M |
Operating profit | -86.42%7.5M | -65.85%67.99M | -80.19%55.25M | 212.63%199.11M | 378.62%278.83M | 18.65%-176.79M | 11.56%-100.08M | -204.14%-217.3M | -1,080.50%-113.16M | -340.69%-71.45M |
Financing cost | -22.50%-7.37M | 61.35%-13.38M | 77.13%-6.02M | 20.02%-34.62M | -19.20%-26.32M | -3.54%-43.29M | 13.83%-22.08M | 30.48%-41.81M | -32.56%-25.62M | -256.70%-60.14M |
Earning before tax | -99.74%127K | -66.80%54.61M | -80.51%49.23M | 174.74%164.49M | 306.71%252.51M | 15.06%-220.08M | 11.98%-122.16M | -96.91%-259.11M | -379.96%-138.79M | -297.87%-131.59M |
Tax | ---- | -123.43%-640K | ---568K | -31.70%2.73M | ---- | 480.55%4M | 99.46%-7K | -28.75%689K | -116.64%-1.29M | 114.79%967K |
After-tax profit from continuing operations | -99.74%127K | -67.72%53.97M | -80.73%48.66M | 177.39%167.22M | 306.70%252.51M | 16.39%-216.08M | 12.79%-122.16M | -97.84%-258.42M | -374.65%-140.08M | -229.74%-130.62M |
Earning after tax | -99.74%127K | -67.72%53.97M | -80.73%48.66M | 177.39%167.22M | 306.70%252.51M | 16.39%-216.08M | 12.79%-122.16M | -97.84%-258.42M | -374.65%-140.08M | -229.74%-130.62M |
Minority profit | ---- | ---- | ---- | ---- | ---- | 124.54%660K | 98.25%-20K | -176.36%-2.69M | ---1.14M | ---973K |
Profit attributable to shareholders | -99.74%127K | -67.72%53.97M | -80.73%48.66M | 177.15%167.22M | 306.73%252.51M | 15.25%-216.74M | 12.08%-122.14M | -97.25%-255.73M | -370.78%-138.93M | -227.29%-129.65M |
Basic earnings per share | -68.75%0.015 | -80.56%0.014 | 176.19%0.048 | 300.00%0.072 | 16.00%-0.063 | 12.20%-0.036 | -97.37%-0.075 | -355.56%-0.041 | -216.67%-0.038 | |
Diluted earnings per share | -68.75%0.015 | -80.56%0.014 | 176.19%0.048 | 300.00%0.072 | 16.00%-0.063 | 12.20%-0.036 | -97.37%-0.075 | -355.56%-0.041 | -216.67%-0.038 | |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.